About Edwards Lifesciences
Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
Dedicated to improving the lives of patients with structural heart disease, our commitment to transformational heart valve technology began in 1960 with the first commercially available heart valve. Edwards has continued to meaningfully advance heart valve therapy, and, more than 50 years later, we remain a global leader in this field. Our offerings include tissue replacement heart valves and repair products, as well as transcatheter heart valves for those patients considered at intermediate or greater risk for conventional valve replacement.
SAPIEN 3 Ultra Higher Standard